C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients

Area of Science:

• Cardiovascular Science
• Nephrology
• Inflammation Biology

Background:

• Inflammation is central to atherosclerosis development and progression.
• C-reactive protein (CRP) is a key inflammatory marker linked to mortality, especially in dialysis patients.
• CRP levels are significantly elevated in hemodialysis patients due to multifactorial causes.

Purpose of the Study:

• To explore the origins of elevated C-reactive protein (CRP) in hemodialysis patients.
• To investigate the role of endogenous and exogenous factors in triggering inflammatory responses.
• To examine whether CRP is a marker or a causal factor in cardiovascular disease pathogenesis.

Main Methods:

• Review of in vitro studies identifying endogenous factors (e.g., angiotensin II, modified LDL) triggering NF-kappaB-mediated inflammation.
• Analysis of clinical studies identifying exogenous factors (e.g., dialysate endotoxin, dialyzer material) contributing to high CRP.
• Examination of recent data on CRP's direct role in disease mechanisms, including complement activation and tissue factor expression.

Main Results:

• Multiple endogenous factors (angiotensin II, modified LDL, etc.) and exogenous factors (dialysate endotoxin, dialyzer material) contribute to elevated CRP in hemodialysis patients.
• These factors trigger inflammatory pathways, often involving nuclear factor-kappaB (NF-kappaB), interleukin-6 (IL-6), and oxidative stress.
• Some identified factors are also non-traditional cardiovascular risk factors.

Conclusions:

• Elevated CRP in hemodialysis patients is multifactorial, driven by both endogenous and exogenous stimuli.
• Emerging evidence suggests CRP may actively participate in atherosclerosis pathogenesis, not merely serve as a marker.
• Further research is needed to clarify CRP's precise role in cardiovascular disease development and outcomes.